Scandium Muriaticum (Hahnemann Laboratories, Inc.)
Welcome to the PulseAid listing for the Scandium Muriaticum drug offered from Hahnemann Laboratories, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hahnemann Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Scandium Muriaticum |
| SUBSTANCE NAME: | SCANDIUM CHLORIDE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | BUCCAL; ORAL; SUBLINGUAL |
| DOSAGE FORM: | PELLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2017-05-04 |
| END MARKETING DATE: | 0000-00-00 |
Scandium Muriaticum HUMAN OTC DRUG Details:
| Item Description | Scandium Muriaticum from Hahnemann Laboratories, Inc. |
| LABELER NAME: | Hahnemann Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30([hp_C]/[hp_C]) |
| START MARKETING DATE: | 2017-05-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63545-687_4eba86c2-61d5-1002-e054-00144ff8d46c |
| PRODUCT NDC: | 63545-687 |
| APPLICATION NUMBER: | |
Other SCANDIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:
